4//SEC Filing
BESHAR LUKE M 4
Accession 0000899243-21-030838
CIK 0001850838other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 5:05 PM ET
Size
5.5 KB
Accession
0000899243-21-030838
Insider Transaction Report
Form 4
BESHAR LUKE M
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-07-29+52,941→ 52,941 totalExercise: $17.00Exp: 2031-07-28→ Common Stock (52,941 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable with respect to 25% of the underlying shares on June 2, 2022 and in 36 equal monthly installments thereafter such that the option will become fully vested and exercisable on June 22, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
Omega Therapeutics, Inc.
CIK 0001850838
Entity typeother
Related Parties
1- filerCIK 0001192128
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 5:05 PM ET
- Size
- 5.5 KB